Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemisia Annua Infusion for Asymptomatic Plasmodium Falciparum Infection
NCT07819825Phase 1Not yet recruiting
- Sponsor
- Centre de Recherches Médicales de Lambaréné
- Start
- Sep 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Phase 1, randomised trial of artemisia annua in malaria (2 arms), sponsored by Centre de Recherches Médicales de Lambaréné. Primary endpoint: Number of participants in whom the parasitaemia was cleared at 7 days. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
artemisia annua
03
Conditions
malaria
Beyond the preview
Go deeper on NCT07819825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07819825.